Trials / Conditions / Neuroendocrine Prostate Cancer (NEPC)
Neuroendocrine Prostate Cancer (NEPC)
3 registered clinical trials studyying Neuroendocrine Prostate Cancer (NEPC) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, i NCT07488923 | Moonlight Bio, Inc | Phase 1 |
| Not Yet Recruiting | Memantine Hydrochloride in Prostate Cancer Patients NCT07164794 | Bin Xu | Phase 2 |
| Recruiting | A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) NCT05652686 | Phanes Therapeutics | Phase 1 / Phase 2 |